Veritas Asset Management LLP has added 852,854 shares of $BDX to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 09-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $BDX.
BECTON, DICKINSON Hedge Fund Activity
We have seen 752 institutional investors add shares of BECTON, DICKINSON stock to their portfolio, and 797 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 4,598,284 shares (-53.5%) from their portfolio in Q2 2025, for an estimated $792,054,419
- VANGUARD GROUP INC added 4,305,947 shares (+15.4%) to their portfolio in Q2 2025, for an estimated $741,699,370
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,603,168 shares (+28.7%) to their portfolio in Q2 2025, for an estimated $620,645,688
- BLACKROCK, INC. added 3,389,963 shares (+14.2%) to their portfolio in Q2 2025, for an estimated $583,921,126
- FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 3,268,478 shares (+59.2%) to their portfolio in Q2 2025, for an estimated $562,995,335
- GQG PARTNERS LLC removed 3,011,583 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $518,745,171
- GENERATION INVESTMENT MANAGEMENT LLP removed 2,537,140 shares (-47.9%) from their portfolio in Q2 2025, for an estimated $437,022,365
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BECTON, DICKINSON Insider Trading Activity
BECTON, DICKINSON insiders have traded $BDX stock on the open market 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:
- GREGORY HAYES purchased 5,250 shares for an estimated $1,005,742
- CLAIRE FRASER has made 0 purchases and 2 sales selling 1,780 shares for an estimated $337,892.
- MICHAEL DAVID GARRISON (EVP & President, Medical) has made 0 purchases and 2 sales selling 1,185 shares for an estimated $213,644.
- DAVID SHAN (EVP and Chief ISC Officer) sold 1,166 shares for an estimated $199,607
- MICHAEL FELD (EVP & President, Life Sciences) has made 0 purchases and 3 sales selling 172 shares for an estimated $32,387.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BECTON, DICKINSON Government Contracts
We have seen $77,210,110 of award payments to $BDX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- INFUSION PUMPS MULTIPLE-AWARD IDIQ VISN 10 ORDER: $5,252,124
- INFUSION PUMPS: $5,057,297
- 8511358199!PHARMACY AUTOMATION MAINTENAN: $4,072,311
- FLEET REPLACEMENT INFUSION PUMPS: $2,996,961
- INFUSION PUMPS IN SUPPORT OF VA PUGET SOUND HEALTHCARE SYSTEM, SEATTLE WA: $2,390,729
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
BECTON, DICKINSON Congressional Stock Trading
Members of Congress have traded $BDX stock 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/17 and 1 sale worth up to $15,000 on 06/24.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 05/15.
- REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 05/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
BECTON, DICKINSON Analyst Ratings
Wall Street analysts have issued reports on $BDX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 06/03/2025
To track analyst ratings and price targets for BECTON, DICKINSON, check out Quiver Quantitative's $BDX forecast page.
BECTON, DICKINSON Price Targets
Multiple analysts have issued price targets for $BDX recently. We have seen 6 analysts offer price targets for $BDX in the last 6 months, with a median target of $198.5.
Here are some recent targets:
- Shagun Singh from RBC Capital set a target price of $211.0 on 10/16/2025
- Patrick Wood from Morgan Stanley set a target price of $197.0 on 08/11/2025
- Jason Bednar from Piper Sandler set a target price of $200.0 on 08/08/2025
- Lawrence Biegelsen from Wells Fargo set a target price of $184.0 on 08/08/2025
- Matt Miksic from Barclays set a target price of $241.0 on 06/03/2025
- Joanna Wiensch from Citigroup set a target price of $185.0 on 05/22/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $BDX ticker page for more data.
